Literature DB >> 1324509

Focal liver disease: comparison of dynamic contrast-enhanced CT and T2-weighted fat-suppressed, FLASH, and dynamic gadolinium-enhanced MR imaging at 1.5 T.

R C Semelka1, J P Shoenut, M A Kroeker, H M Greenberg, F C Simm, G Y Minuk, R M Kroeker, A B Micflikier.   

Abstract

Dynamic contrast medium-enhanced computed tomography (CT), T2-weighted fat-suppressed spin-echo (T2FS) magnetic resonance (MR) imaging, and breath-hold T1-weighted fast low-angle shot (FLASH) MR imaging before and after dynamic gadopentetate dimeglumine injection were compared in 73 patients with clinically suspected liver disease. Observer confidence for presence of focal lesions was determined by using receiver operating characteristic analysis. For all MR images, hepatic lesion-liver signal-to-noise ratios were evaluated qualitatively. and resolution and presence of artifacts were evaluated qualitatively. Lesion detection was greatest with T2FS (n = 272) and enhanced FLASH (n = 244) and was statistically greater with both of these than with CT (n = 220) and FLASH (n = 219) (P less than .03). Correct lesion characterization was greatest with enhanced FLASH (n = 236) (P less than .01), followed by CT (n = 199), FLASH (n = 164), and T2FS (n = 144). Enhanced FLASH was particularly successful in characterization of 5-mm- to 1.5-cm-diameter lesions as cystic or solid.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1324509     DOI: 10.1148/radiology.184.3.1324509

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  18 in total

1.  Characterisation of small hypoattenuating hepatic lesions in multi-detector CT (MDCT) in patients with underlying extrahepatic malignancy: added value of contrast-enhanced MR images.

Authors:  Song-Ee Baek; Mi-Suk Park; Hye Sook Hong; Jin Young Choi; Yong Eun Chung; Joon Seok Lim; Myeong-Jin Kim; Ki Whang Kim
Journal:  Eur Radiol       Date:  2010-07-09       Impact factor: 5.315

2.  Diagnostic value of diffusion weighted MRI and ADC in differential diagnosis of cavernous hemangioma of the liver.

Authors:  Ozlem Tokgoz; Ebru Unlu; Ilker Unal; Ismail Serifoglu; Ilker Oz; Elif Aktas; Emrah Caglar
Journal:  Afr Health Sci       Date:  2016-03       Impact factor: 0.927

3.  MR-arterioportography: a new technical approach for detection of liver lesions.

Authors:  Janine Rennert; Ernst-Michael Jung; Andreas G Schreyer; Patrick Hoffstetter; Peter Heiss; Stefan Feuerbach; Niels Zorger
Journal:  World J Gastroenterol       Date:  2011-04-07       Impact factor: 5.742

Review 4.  MRI of the liver--how to do it.

Authors:  Shreyas S Vasanawala
Journal:  Pediatr Radiol       Date:  2010-04

5.  Enhancement characteristics of hepatic focal nodular hyperplasia and its scar by dynamic magnetic resonance imaging.

Authors:  L Martí-Bonmatí; C Casillas; R Dosdá
Journal:  MAGMA       Date:  2000-07       Impact factor: 2.310

6.  Ciliated hepatic foregut cysts: US, CT, and contrast-enhanced MR imaging.

Authors:  J P Shoenut; R C Semelka; C Levi; H Greenberg
Journal:  Abdom Imaging       Date:  1994 Mar-Apr

7.  MR imaging of focal liver lesions: comparison between turbo spin-echo and conventional spin-echo pulse sequences.

Authors:  A Giovagnoni; E Paci; P Ercolani; B Kiefer; P Santino; A Piga
Journal:  MAGMA       Date:  1995 Sep-Dec       Impact factor: 2.310

8.  Contributions of Magnetic Resonance Imaging to Gastroenterological Practice: MRIs for GIs.

Authors:  Christopher G Roth; Dina Halegoua-De Marzio; Flavius F Guglielmo
Journal:  Dig Dis Sci       Date:  2018-05       Impact factor: 3.199

9.  MRI characterization of 124 CT-indeterminate focal hepatic lesions: evaluation of clinical utility.

Authors:  Khaled M Elsayes; John R Leyendecker; Christine O Menias; Erica P Oliveira; Vamsidhar R Narra; William C Chapman; Moataz H Hassanien; Mohamed S Elsharkawy; Jeffrey J Brown
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

Review 10.  Contrast agents for hepatic MRI.

Authors:  Giovanni Morana; Elisabetta Salviato; Alessandro Guarise
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.